GLAZER CAPITAL, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001076809

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFinancials TiltHigh Turnover how tags are computed

Q2 2026 · 536 positions · Total reported value $3.35B · Top-10 concentration 38.1% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 63.6% · 188 new · 108 cut · 124 exited

Active Share (vs S&P 500): 99.4% · vs QQQ: 99.2% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, GLAZER CAPITAL, LLC disclosed 536 equity positions with a combined reported value of $3.35B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 38.1% of reported value. HoldingsHub classifies the profile as Mid / Financials Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were JHG ($324.19M), APGE ($217.82M), SEM ($177.28M). By sector, the heaviest allocations are Financials 36.4%, Industrials 4.7%. Versus the prior quarter, allocation shifted toward Financials (+9.5pp), Industrials (+3.2pp) and away from Technology (-1.0pp), Other (-16.1pp).

Versus the prior quarter, GLAZER CAPITAL, LLC opened 188 new positions, trimmed 108 and fully exited 124, a turnover rate of 63.6% of positions. The portfolio's overlap with the prior quarter was 53% of names.

The largest new positions opened in Q2 2026 were APGE ($217.82M), CPRX ($113.24M), HBM ($83.75M).

Of the 124 positions fully exited versus the prior quarter, the largest were AL ($350.66M), HOLX ($269.38M), SEE ($213.97M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • APGE APOGEE THERAPEUTICS INC · $217.82M
  • CPRX CATALYST PHARMACEUTICALS INC · $113.24M
  • HBM HUDBAY MINERALS INC · $83.75M
  • ESPR ESPERION THERAPEUTICS INC NE · $70.84M
  • SILA SILA REALTY TRUST INC · $68.11M
  • GBTG GLOBAL BUSINESS TRAVEL GROUP · $48.03M
  • DASH DOORDASH INC · $44.09M
  • ACA ARCOSA INC · $36.34M

Fully Exited (vs previous quarter)

  • AL AIR LEASE CORP · prev qtr: $350.66M
  • HOLX HOLOGIC INC · prev qtr: $269.38M
  • SEE SEALED AIR CORP NEW · prev qtr: $213.97M
  • CWAN CLEARWATER ANALYTICS HLDGS I · prev qtr: $184.94M
  • FOLD AMICUS THERAPEUTICS INC · prev qtr: $183.97M
  • OS ONESTREAM INC · prev qtr: $180.90M
  • TERN TERNS PHARMACEUTICALS INC · prev qtr: $121.02M
  • TPH TRI POINTE HOMES INC · prev qtr: $104.46M

Insider Transactions (Form 4)

Latest GLAZER CAPITAL, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Glazer Capital is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 536 US equity positions with a combined value of $3.35B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-65644 (status: Approved), registered 2006-09-11
  • Regulatory AUM (Form ADV): $6.81B as of 2026-03-24
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: glazercapital.com

Portfolio Structure

  • 536 positions · $3.35B reported value (Q2 2026)
  • Top 10 holdings = 38.1% of reported value
  • Largest position: JHG (JANUS HENDERSON GROUP PLC) at 9.7%
  • Average position size: $6.25M

Sector Tilt

  • Financials 36.4%
  • Industrials 4.7%
  • Consumer Discretionary 3.2%
  • (classified holdings cover 51% of value)

Quarterly Activity

  • Q2 2026: 188 new, 85 added, 108 reduced, 124 exited
  • 155 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Financials 36.4%
Materials 2.5%
Technology 0.9%
Other 50.1%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 6.23M $324.19M 9.68%
9.68%
Add
2 1.64M $217.82M 6.50%
6.50%
New
3 10.74M $177.28M 5.29%
5.29%
Add
4 3.60M $113.24M 3.38%
3.38%
New
5 3.55M $83.75M 2.50%
2.50%
New
6 4.93M $77.75M 2.32%
2.32%
Reduce
7 357.76K $74.75M 2.23%
2.23%
Add
8 22.42M $70.84M 2.11%
2.11%
New
9 905.96K $69.23M 2.07%
2.07%
Add
10 2.24M $68.11M 2.03%
2.03%
New
11 5.12M $48.03M 1.43%
1.43%
New
12 44.85M $44.09M 1.32%
1.32%
New
13 250.09K $36.34M 1.08%
1.08%
New
14 1.88M $35.71M 1.07%
1.07%
New
15 1.20M $31.57M 0.94%
0.94%
New
16 895.70K $29.79M 0.89%
0.89%
Add
17 12.30M $29.76M 0.89%
0.89%
Add
18 5.87M $29.58M 0.88%
0.88%
New
19 200.67K $27.72M 0.83%
0.83%
New
20 1.69M $24.77M 0.74%
0.74%
Add
21 2.34M $23.57M 0.70%
0.70%
Hold
22 2.16M $21.78M 0.65%
0.65%
Hold
23 2.16M $21.43M 0.64%
0.64%
Reduce
24 2.03M $20.69M 0.62%
0.62%
Add
25 1.80M $18.76M 0.56%
0.56%
Add
26 323.59K $18.37M 0.55%
0.55%
New
27 1.60M $16.54M 0.49%
0.49%
Add
28 1.60M $16.24M 0.48%
0.48%
Add
29 1.63M $16.13M 0.48%
0.48%
Add
30 1.61M $16.08M 0.48%
0.48%
Hold
31 1.56M $16.08M 0.48%
0.48%
Add
32 1.52M $15.79M 0.47%
0.47%
Add
33 1.50M $15.26M 0.46%
0.46%
Hold
34 1.44M $15.11M 0.45%
0.45%
Reduce
35 1.50M $15.02M 0.45%
0.45%
Hold
36 1.50M $14.92M 0.45%
0.45%
New
37 1.47M $14.70M 0.44%
0.44%
Hold
38 1.11M $14.69M 0.44%
0.44%
New
39 1.45M $14.57M 0.43%
0.43%
Add
40 1.44M $14.17M 0.42%
0.42%
New
41 200.00K $14.13M 0.42%
0.42%
New
42 1.40M $14.08M 0.42%
0.42%
Add
43 1.30M $13.71M 0.41%
0.41%
Hold
44 1.35M $13.68M 0.41%
0.41%
Add
45 1.30M $13.59M 0.41%
0.41%
Hold
46 1.30M $12.87M 0.38%
0.38%
New
47 449.92K $12.81M 0.38%
0.38%
New
48 1.26M $12.80M 0.38%
0.38%
Hold
49 1.20M $12.73M 0.38%
0.38%
Hold
50 1.23M $12.68M 0.38%
0.38%
Hold

FAQ

What did GLAZER CAPITAL, LLC buy in 2026-Q2?

In its 2026-Q2 13F filing, GLAZER CAPITAL, LLC reported 536 equity positions worth $3.35B in aggregate; its largest disclosed positions were JHG ($324.19M), APGE ($217.82M), SEM ($177.28M).

How large is GLAZER CAPITAL, LLC's portfolio?

GLAZER CAPITAL, LLC reported $3.35B of long equity holdings across 536 positions as of 2026-Q2. Top-10 holdings account for 38.1% of reported value.

What is GLAZER CAPITAL, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Financials Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/glazer-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →